Facts About Eczema: 15 Things Science Wants You to Know

Facts About Eczema: 15 Things Science Wants You to Know
By David Lee, Clinical Research Coordinator •

Everything you thought you knew about eczema might be incomplete. Over 230 million people worldwide live with atopic dermatitis, making it one of the most common skin conditions on the planet.[1] Yet many of the most important facts about eczema rarely make it into everyday conversation.

If you or someone you love deals with eczema, you already know the itch, the frustration, and the trial-and-error of finding relief. What you may not know is how deeply this condition reaches into sleep, mental health, and even your wallet.

This article shares 15 facts about eczema backed by peer-reviewed research. Some will confirm what you suspect. Others may change how you think about your skin. Along the way, you will find links to deeper guides on topics like the root causes of atopic dermatitis and practical management strategies.

Global burden studies rank eczema among the top 50 most impactful diseases worldwide when measured by disability-adjusted life years.[2] The 15 facts below explain why.

Key Takeaways

  • Up to 20% of children and 10% of adults have eczema worldwide.
  • Eczema involves far more than dry skin or a simple rash.
  • Eczema is not contagious, but secondary infections can be.
  • Sleep loss from eczema costs billions in productivity each year.
  • New biologics and JAK inhibitors are changing outcomes for severe cases.

Table of Contents

Who Gets Eczema: Prevalence and Demographics

The sheer number of people affected by eczema surprises most people, even doctors. These prevalence facts put the condition in perspective.

1. Up to 20% of Children Develop Eczema

Atopic dermatitis is the most common chronic skin disease in childhood. Across multiple countries, prevalence rates land between 15% and 20% in children under age 5, which means roughly one in five kids will experience eczema at some point.[3]

Most cases appear early. About 60% begin during the first year of life, often before a child can even tell you something is wrong.[4] That means parents are usually the first to notice: a patch of rough, red skin on a cheek or the crook of an elbow.

2. Adults Get Eczema Too

Eczema is not just a childhood condition. Adult prevalence ranges from 2% to 10% depending on the country, and some adults develop it for the first time in their 20s or 30s.[5] Dermatologists call this adult-onset atopic dermatitis, and it can be especially confusing for people who never had skin problems as kids. Our guide to eczema across age groups explains how the condition changes in presentation, location, and severity from infancy through adulthood.

3. Geography Matters

Eczema rates vary dramatically by region. Industrialized countries report higher prevalence than rural or developing regions, and urban living, reduced microbial exposure, and Western diets may all play a role.[6] Researchers call this the "hygiene hypothesis": children who grow up in too-clean environments may never train their immune systems to tell harmless substances from real threats.

4. Genetics Load the Gun

If one parent has eczema, a child's risk roughly doubles. If both parents have it, the risk climbs to 3 to 5 times higher than average.[7] Mutations in the filaggrin gene, which helps build the skin barrier, account for a significant portion of this inherited risk. You can explore the full genetic picture in our guide to eczema and genetics. For a broader look at how family history shapes your risk, see Is Atopic Dermatitis Hereditary? Family Risk Explained.

Chart showing eczema prevalence facts by age group from childhood to adulthood

What Happens Inside Eczema Skin

Understanding the biology matters because it changes how you treat the problem. Eczema is far more than "dry skin." Here is what is actually going wrong beneath the surface.

5. Your Skin Barrier Leaks Water

Healthy skin loses a small, controlled amount of water through evaporation, a process called transepidermal water loss (TEWL). In eczema, that process spirals out of control. TEWL rates in active lesions run two to three times higher than in healthy skin.[8] That tight, papery feeling after a shower? It is your barrier failing to hold moisture in.

Picture a roof with missing shingles. Rain gets in. Heat escapes. That is your skin barrier in eczema. For a deeper look at this process, see our article on the root causes of atopic dermatitis.

6. The Microbiome Shifts Dramatically

Your skin hosts trillions of microorganisms, and in eczema, the balance tips hard. During flares, Staphylococcus aureus colonizes up to 90% of eczema skin, compared to about 5% of healthy skin.[9] If you have ever noticed a flare that smells different or oozes a yellowish crust, that is often staph at work. This bacterial takeover drives inflammation and worsens symptoms. Learn more about how bacteria interact with eczema in our guide to eczema and antibiotics treatment.

The practical takeaway: eczema is partly a microbial problem, not just an immune or barrier problem. Learn more about what the microbiome is and how it impacts eczema.

7. More Than Seven Subtypes Exist

Most people think of eczema as one condition, but at least seven different types exist: atopic dermatitis, contact dermatitis, dyshidrotic eczema, nummular eczema, and more. Each has distinct triggers, locations, and treatment needs, which is why a cream that works for one type may do nothing for another.

8. The Immune System Overreacts

Eczema involves a Th2-dominant immune response, which means certain immune cells flood the skin with inflammatory signals, especially interleukin-4 (IL-4) and interleukin-13 (IL-13).[10] These signals drive itch, redness, and barrier breakdown in a self-reinforcing cycle: you scratch, the barrier cracks further, more irritants get in, and the immune system ramps up again. For a deeper look at how the immune system drives eczema, see our guide on whether atopic dermatitis is an autoimmune disorder.

Process diagram showing how eczema disrupts the skin barrier step by step

📚 Related Resource

See our guide: What Causes Eczema Flare-Ups? 7 Triggers Backed by Science

Eczema Myths vs. Reality

Because misinformation leads to shame, delayed treatment, and poor decisions, these myths deserve a direct response. The facts below set the record straight.

9. Eczema Is Not Contagious

You cannot catch eczema from another person, no matter how close the contact. It is not caused by a virus, bacterium, or fungus but by a combination of genetic, immune, and environmental factors.[11] One important caveat: secondary skin infections that sometimes develop on eczema skin can be contagious. Learn more in our guide on whether eczema can spread.

10. Eczema Is Not Caused by Poor Hygiene

This myth causes real stigma, and the irony cuts deep: overwashing and harsh soaps actually damage the skin barrier and make eczema worse.[12] Gentle cleansing beats aggressive scrubbing every time. Our guide on the worst ingredients for eczema identifies the specific cleansing agents most likely to trigger flares.

11. Stress Does Not "Cause" Eczema, but It Fuels Flares

Stress alone does not create eczema. But if you have ever noticed a flare during a deadline week or after a family argument, your instinct is backed by science: psychological stress triggers measurable increases in cortisol and inflammatory markers that worsen existing disease.[13] The relationship runs both ways. Eczema causes stress, and stress worsens eczema.

Infographic comparing common eczema myths versus evidence-based facts

The Hidden Burden: Quality of Life and Cost

The facts that get the least attention may matter the most, because eczema does not stop at the skin. It follows people to work, to school, and into bed at night.

12. Eczema Steals Sleep

Nighttime itch is one of the most disabling symptoms. Children with moderate-to-severe eczema lose an average of 1.9 hours of sleep per night during flares.[14] Picture a six-year-old scratching through the sheets at 2 a.m., then dragging through school the next day. Parents lose sleep too, caught in a cycle of checking, soothing, and reapplying cream. Our guide on sleeping with eczema offers practical solutions, and our SmartLotion protocol for adults includes nighttime application guidance.

13. The Economic Burden Is Massive

In the United States alone, the annual cost of atopic dermatitis tops $5 billion when combining direct medical costs and lost productivity.[15] That number includes the dermatologist visits, the prescription copays, and the workdays lost when a flare makes it impossible to concentrate. Adults with moderate-to-severe eczema miss more workdays and report lower on-the-job productivity than those without the condition.

⚠️ Mental Health Alert:

Adults with atopic dermatitis have significantly higher rates of depression and anxiety compared to the general population.[16] If eczema affects your mood, talk to your doctor. Our guide on stress and eczema explains the two-way relationship between mental health and skin symptoms.

14. Children with Eczema Face Bullying

Visible skin conditions affect self-esteem, especially in young people. Research shows children with eczema experience higher rates of teasing and social exclusion.[17] The psychological toll can persist into adulthood. If this resonates, our guide on feeling confident with eczema offers evidence-based strategies. Teenagers face particular challenges — see our dedicated guide on eczema in teens.

Data visualization showing eczema quality of life impact including sleep loss and mental health

Facts About Eczema Treatment Today

Because eczema involves the barrier, the immune system, and the microbiome all at once, treatment has historically been frustrating. That is changing. The treatment landscape has shifted more in the last decade than in the previous fifty years, and these facts offer real hope.

15. New Treatments Are Changing Outcomes

Biologic therapies like dupilumab have transformed care for moderate-to-severe eczema, with clinical trials showing that roughly 40% of patients achieve clear or almost clear skin after 16 weeks.[18] JAK inhibitors offer another new option. Some patients see improvement within the first two weeks, a timeline that would have seemed unrealistic a decade ago.[19]

But not everyone needs advanced therapy. For many, the right combination of barrier repair, trigger avoidance, and a well-formulated eczema cream can make a meaningful difference. Treatments that address both inflammation and the skin microbiome, like SmartLotion, offer a dual-action approach that targets two of the core problems in eczema skin.

What the treatment facts mean for you:

No single treatment works for everyone, which is why matching the approach to your severity and triggers matters so much. Our complete guide to tackling eczema walks through 12 evidence-based strategies to help you find what works.

📚 Related Resource

Learn whether eczema runs in your family: Is Atopic Dermatitis Hereditary? Family Risk Explained

Frequently Asked Questions

Is eczema contagious?

No. Eczema cannot spread from person to person through touch or proximity. It is driven by genetics, immune dysfunction, and environmental factors. However, bacterial or viral infections that develop on eczema skin can be contagious.[11]

Do children outgrow eczema?

Many do. Studies suggest that about 60% to 70% of children with eczema see significant improvement or resolution by adolescence.[4] However, some carry the condition into adulthood, and a subset develops it for the first time as adults.

Is there a cure for eczema?

There is no cure for eczema at this time. However, effective management can achieve long periods of clear or nearly clear skin. Newer therapies continue to improve outcomes for even the most severe cases.[18]

Does food cause eczema?

Food does not cause eczema. In some people, specific foods can trigger flares, but this affects a minority of eczema patients. Elimination diets should only be done under medical supervision.[21] For a full evidence-based review, see our guide on diet and eczema.

References

  1. Ou Y, Shao X, Zhang J, Chen J. "Global, regional, and national burden of older adult atopic dermatitis in 204 countries and territories worldwide." Frontiers in Public Health. 2025. View Study
  2. Ali F, Vyas J, Finlay AY. "Counting the Burden: Atopic Dermatitis and Health-related Quality of Life." Acta Dermato-Venereologica. 2020. View Study
  3. Ab Hadi H, Tarmizi AI, Khalid KA, Gajdács M, Aslam A, Jamshed S. "The Epidemiology and Global Burden of Atopic Dermatitis: A Narrative Review." Life (Basel). 2021. View Study
  4. Abuabara K, Yu AM, Okhovat J-P, Allen IE, Langan SM. "The prevalence of atopic dermatitis beyond childhood: A systematic review and meta-analysis of longitudinal studies." Allergy. 2018. View Study
  5. Chiang BM, Ye M, Chattopadhyay A, Halezeroglu Y, Van Blarigan EL, Abuabara K. "Sodium Intake and Atopic Dermatitis." JAMA Dermatology. 2024. View Study
  6. Lee W, Chaudhary F, Agrawal DK. "Environmental Influences on Atopic Eczema." Journal of Environmental Science and Public Health. 2024. View Study
  7. O'Connor C, Livingstone V, Hourihane JO'B, Irvine AD, Boylan G, Murray D. "Parental atopy and risk of atopic dermatitis in the first two years of life in the BASELINE birth cohort study." Pediatric Dermatology. 2022. View Study
  8. Pretel-Lara C, Sanabria-de la Torre R, Arias-Santiago S, Montero-Vilchez T. "Skin Barrier Function and Microtopography in Patients with Atopic Dermatitis." Journal of Clinical Medicine. 2024. View Study
  9. Blicharz L, Usarek P, Młynarczyk G, Skowroński K, Rudnicka L, Samochocki Z. "Is Itch Intensity in Atopic Dermatitis Associated with Skin Colonization by Staphylococcus aureus?" Indian Journal of Dermatology. 2020. View Study
  10. Mitroi GG, Pleșea EL, Mitroi GF, Mitroi MR, Neagoe CD, Ianoși SL. "Exploring the Potential of IL-4 and IL-13 Plasma Levels as Biomarkers in Atopic Dermatitis." Life. 2024. View Study
  11. Afshari M, Kolackova M, Rosecka M, Čelakovská J, Krejsek J. "Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches." Frontiers in Immunology. 2024. View Study
  12. Mijaljica D, Spada F, Harrison IP. "Skin Cleansing without or with Compromise: Soaps and Syndets." Molecules. 2022. View Study
  13. Hall JMF, Cruser D, Podawiltz A, Mummert DI, Jones H, Mummert ME. "Psychological Stress and the Cutaneous Immune Response: Roles of the HPA Axis and the Sympathetic Nervous System in Atopic Dermatitis and Psoriasis." Dermatology Research and Practice. 2012. View Study
  14. Lee DG, Gui XY, Mukovozov I, Fleming P, Lynde C. "Sleep Disturbances in Children With Atopic Dermatitis: A Scoping Review." Journal of Cutaneous Medicine and Surgery. 2023. View Study
  15. Manjelievskaia J, Boytsov N, Brouillette MA, Onyekwere U, Pierce E, Goldblum O, Bonafede M. "The direct and indirect costs of adult atopic dermatitis." Journal of Managed Care & Specialty Pharmacy. 2021. View Study
  16. Zhang J, Loman L, Oldhoff JM, Schuttelaar MLA. "Beyond Anxiety and Depression: Loneliness and Psychiatric Disorders in Adults with Atopic Dermatitis." Acta Dermato-Venereologica. 2023. View Study
  17. Kelly KA, Balogh EA, Kaplan SG, Feldman SR. "Skin Disease in Children: Effects on Quality of Life, Stigmatization, Bullying, and Suicide Risk in Pediatric Acne, Atopic Dermatitis, and Psoriasis Patients." Children (Basel). 2021. View Study
  18. Ständer S, Pinter A, Hougeir FG, et al. "Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison." Dermatology and Therapy. 2025. View Study
  19. Silverberg JI, Boguniewicz M, Waibel J, Weisman J, Strowd L, Sun L, Ding Y, Feely M, Nunes FP, Simpson EL. "Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16." Dermatology and Therapy. 2022. View Study
  20. Sid Idris F. "Treatment of Atopic Dermatitis in Children." Cureus. 2024. View Study
  21. Papapostolou N, Xepapadaki P, Gregoriou S, Makris M. "Atopic Dermatitis and Food Allergy: A Complex Interplay What We Know and What We Would Like to Learn." Journal of Clinical Medicine. 2022. View Study

About the Author: David Lee, Clinical Research Coordinator

David brings cutting-edge dermatology research directly to patients. As our clinical research coordinator, he translates the latest scientific findings into practical insights you can use. When he's not analyzing data or managing clinical trials, David enjoys rock climbing and astronomy, pursuits that highlight his keen eye for detail and understanding of complex systems, skills he applies daily to navigate the intricacies of dermatology research.